Healthy Living/WellnessZydelig (idelalisib) gets FDA approval for 3 types of cancer: Another Gilead blockbuster drug? The FDA has green-lighted a new drug from Gilead Sciences as treatment for three types of blood cancer namely chronic lymphocytic leukemia, follicular B-cell non-Hodgkin lymphoma and small lymphocytic lymphoma.by Rhodi Lee
Healthy Living/WellnessDeath of parents during childhood might shorten lives of individuals: Studyby Dianne Depra
Healthy Living/WellnessPeaches, necterines, plums among nationwide recall for listeriaby James Maynard
Healthy Living/WellnessGlaxoSmithKline wants to bring the world its first malaria vaccineby Rebecca Kaplan
Healthy Living/WellnessObamacare a success? 10.3 million gained health coverage since last Octoberby Rhodi Lee
Healthy Living/WellnessAcetaminophen ineffective in treating back pain: Paracetamol/Tylenol no better than placebo, new study claimsby Rhodi Lee
Healthy Living/WellnessLess-educated choosing healthcare as a career. Over 60 percent of workforce has no bachelor's degreeby Michael McEnaney
Healthy Living/WellnessAcetaminophen might just be placebo when it comes to lower back painby Tina Shah